1. Effects of a novel 5HT1A receptor antagonist UH-301 and (R)-8-OHDPAT on the activity of dorsal raphe (DRN) 5HT neurones and dopamine neurones in the ventral tegmental area (VTA);ARBORELLUS;Serotonin: Animal Models and Clinical Targets,1992
2. 8-hydroxy-2-(di-n-propylamino) tetralin a new centrally acting 5-hydroxytryptamine receptor agonist;ARVIDSSON;J. Med. Chem.,1981
3. 5-HT2 receptor subtypes: a family re-united?;BAXTER;Trends Pharmacol. Sci.,1995
4. 'Wet-dog' shake behaviour in the rat: a possible quantitative model of central 5-hydroxytryptamine activity;BEDARD;Neuropharmacol.,1977
5. Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropyl-amino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropyl-amino)tetralin induced effects;BJORK;J. Pharmacol. Exp. Ther.,1991